Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy

Southern Medical Journal

Volumn 104, Issue 1, 2011, Pages 29-33

  Mikhail, Nasser ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

hypercalcemia; primary hyperparathyroidism; vitamin D; vitamin D therapy

Indexed keywords

CALCIFEDIOL; CALCIUM; COLECALCIFEROL; CREATININE; ERGOCALCIFEROL; VITAMIN D;

ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; COMORBIDITY; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; DRUG SAFETY; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; PARATHYROIDECTOMY; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

HUMANS; HYPERPARATHYROIDISM, PRIMARY; PARATHYROID HORMONE; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 78650908658     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181fcd772     Document Type: Article

References (28)

1. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:340-350.
2. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insuff-iency. Lancet 1998;351:805-806.
3. Woodhouse NJ, Doyle FH, Joplin GF. Vitamin-D deficiency and primary hyperparathyroidism. Lancet 1971;2:283-286.
4. Lumb GA, Stanbury SW. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974;56:833-839.
5. Moosgaard B, Vestergaard P, Heickendorff L, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005;63:506-513.
6. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrinol Metab 2001;86:1212-1221.
7. Boudou P, Ibrahim F, Cormier C, et al. A very high incidence of low 25 hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 2006;29: 511-515.
8. Silverberg SJ, Shane E, Dempster DW, et al. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999;107:561-567.
9. Kandil E, Tufaro AP, Carson KA, et al. Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sistamibi scan. Arch Otolaryngol Head Neck Surg 2008;134:1071-1075.
10. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632.
11. Clements MR, Davies M, Hayes ME, et al. The role of 1,25-dihy- droxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (Oxf) 1992;37:17-27.
12. Davies M, Heys SE, Selby PL, et al. Increased catabolism of 25-hy-droxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxy vitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 1997;82:209-212.
13. Bolland MJ, Grey AB, Gamble GD, et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005;90:1525-1530.
14. Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvi-tamin D levels in healthy men. J Clin Endocrinol Metab 2003;88:157-161.
15. Kantorovich V, Gacad MA, Seeger LL, et al. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:3541-3543.
16. Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: Pathogenetic and clinical implications. J Clin Endocrinol Metab 2000;85:1054-1058.
17. Beyer TD, Chen EL, Nilubol N, et al. Short-term outcomes of parathy-roidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res 2007;143:145-150.
18. Untch BR, Barfield ME, Dar M, et al. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Surgery 2007;142:1022-1026.
19. Stewart ZA, Blackford A, Somervell H, et al. 25-hydroxyvitamin D deficiency is a risk factor for symptoms for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 2005;138:1018-1025.
20. Moosgaard B, Christensen SE, Vestergaard P, et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008;68:707-715.
21. Carnevale V, Manfredi G, Romagnoli E, et al. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal change? Clin Endocrinol (Oxf) 2004;60:81-86.
22. Nordenström E, Westerdahl J, Lindergård B, et al. Multifactorial risk for bone fractures in primary hyperparathyroidism. World J Surg 2002;26: 1463-1467.
23. Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hy-perparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001-3005.
24. Grey A, Lucas J, Horne A, et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005;90:2122-2126.
25. Tucci JR. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol 2009;161:189-193.
26. Isidro ML, Ruano B. Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 2009;36:305-310.
27. Grubbs EG, Rafeeq S, Jimenez C, et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 2008;144:852-858.
28. Carter GD, Berry JL, Gunter E, et al. Proficiency testing of 25-hy-droxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 2010;121:176-179.